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Abstract
Background: Most of studies on the relationship between drug use and HIV have focused largely on people who inject
drugs. Non-injecting drug use is much more common than injecting drug use, and although it can also predispose
people to HIV infection, it is not widely explored. We therefore conducted this study to explore the prevalence of HIV and
identify risk factors for HIV infection among people who use non-injecting drugs (PWUD) in Cambodia.
Methods: This cross-sectional study was conducted in 2017. The Respondent Driven Sampling method was used to
recruit the study participants who were interviewed face-to-face using a structured questionnaire. Blood samples were
collected for HIV and syphilis testing. A multivariable logistic regression analysis was conducted to identify risk factors
associated with HIV infection.
Results: In total, 1367 PWUD were included in this study, whose mean age was 28.0 (SD = 7.7) years. The majority (95.1%)
of the participants used methamphetamine. The prevalence of HIV was 5.7, and 35.2% of the identified HIV-positive
PWUD were not aware of their status prior to the survey. After adjustment for other covariates, HIV infection remained
significantly associated with being in the age group of ≥35 (AOR = 2.34, 95% CI = 1.04–6.11), having lower level of formal
education of ≤ 6 years (AOR = 2.26, 95% CI = 1.04–5.15), living on the streets (AOR = 2.82, 95% CI = 1.10–7.23), perception
that their HIV risk was higher as compared to that of the general population (AOR = 3.18, 95% CI = 1.27–8.62), having used
injecting drugs in lifetime (AOR = 3.8, 95% CI = 1.36–4.56), and having cuts or sores around the genital area in the past 12
months (AOR = 3.42, 95% CI = 1.09–6.33).
Conclusions: The prevalence of HIV among PWUD in this study was more than 10 times higher than the prevalence in
the general adult population. The findings reveal a higher vulnerability to HIV infection among specific sub-populations of
PWUD, such as those who are homeless, who may benefit from tailored interventions that respond to their specific
needs. To enhance HIV case finding, stratification of PWUD to facilitate HIV risk profiling based on socio-economic profiles
and drug injection history is recommended.
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Background
Illicit drug use is a significant global health problem. An-
nually, a quarter of a billion people use at least one illicit
drug, with cannabis, amphetamines, cocaine, and heroin
being the most common [1]. Evidence from a recent sys-
tematic review suggested that illicit drug dependence
directly accounted for 20 million disability-adjusted life
years (DALYs) in 2010, representing 0.8% of global all-
cause DALYs [2]. This burden of disease is exacerbated
by the intersection between the use of illicit drugs, poor
mental health, and suicides [2, 3].
In Cambodia, people who use drugs (PWUD), particu-
larly people who inject drugs (PWID), are considered an
important group for HIV prevention and harm reduc-
tion programs. The current Cambodia 3.0 framework
aims to eliminate new HIV infections in the country by
2020, by accelerating prevention among all key popula-
tions including PWUD and PWID, female entertainment
workers, men who have sex with men, and transgender
women [4]. To achieve this goal, a key emphasis in the
national response is an aspiration to strengthen the
availability of data and strategic information related to
the HIV epidemic among the key populations [5].
In relation to illicit drug use, however, greater emphasis
in Cambodia has been placed on PWID with limited at-
tention to people who use drugs via non-injecting modes
[5, 6]. While injection of illicit drugs clearly increases the
risk of HIV and viral hepatitis infections [7, 8], ignoring
non-injecting consumption of illicit drugs will prevent the
achievement of the Cambodian national goal of eliminat-
ing HIV infection. We argue that focusing on wider sub-
stance abuse is important for two reasons. First, the use of
illicit drugs, particularly stimulants, has been shown to in-
crease risk of HIV, regardless of injection [7]. Secondly,
the use of illicit drugs such as cannabis, amphetamines,
cocaine, or heroin frequently occurs alongside the con-
sumption of other substances such as alcohol and tobacco
[9, 10], which have their own impacts on health and health
behaviors. For instance, the concomitant use of alcohol
alongside the illicit drugs has been shown to further com-
promise HIV prevention by reducing condom use [11].
In the Cambodian context, PWUD are specifically de-
fined as people who have used any types of illicit drugs,
as specified in the Cambodian Law on Control of Drugs,
via any route of administration other than injection in
the past 12 months [12]. In 2012, it was estimated that
there were 13,000 PWUD and 1300 PWID nationally
[4]. A more recent size estimation exercise conducted
alongside this national survey concluded that there were
22,374 PWUD and 4136 PWID in the country in 2017
[13]. In both of these estimates, PWID were not sub-
sumed under PWUD. Despite the large numbers of
PWUD, studies focusing on this population are limited.
Rare studies have shown that PWUD in Cambodia have
an increased risk of mental health problems [14]. How-
ever, further data related to this population are needed
to inform HIV prevention and other public health inter-
ventions. Accordingly, characterization of the extent and
risk factors of non-injecting drug use was purposely em-
phasized in this Integrated Biological and Behavioral
Survey (IBBS 2017). In this paper, we reported the
prevalence of HIV and factors associated with HIV infec-
tion among PWUD in Cambodia. We also discussed the
potential implications of these findings on HIV preven-
tion policies and programs.
Methods
Study design, sites, and participants
This cross-sectional IBBS 2017 among PWUD and
PWID in Cambodia was conducted from June to De-
cember 2017 in the capital city of Phnom Penh and 11
other major provinces purposively selected by the re-
search team and approved by the National Center for
HIV/AIDS, Dermatology and STD (NCHADS) and Na-
tional Authority for Combating Drugs (NACD). These
study sites were selected based on results from a feasibil-
ity assessment conducted as part of the study designing
and protocol development. About 70% of the Cambo-
dian population resides in the 12 provinces out of 25
provinces in Cambodia. The 12 provinces included: Ban-
teay Meanchey, Battambang, Kampong Cham, Kampong
Chhnang, Kampong Speu, Kandal, Phnom Penh, Preah
Sihanouk, Prey Veng, Siem Reap, Svay Rieng, and Tbong
Khmum. According to the national epidemiological data
from NCHADS and size estimation studies, the selected
sites consisted of 21 operational districts with a high
burden of HIV and drug use, i.e. more than 80% of esti-
mated drug use in Cambodia. To be included in the
study, an individual must: (1) be at least 18 years old; (2)
have a valid study coupon; (3) have not participated in this
survey before; (4) meet the criteria defining PWUD; and (5)
be able and willing to provide a written informed consent.
Sample size and sampling procedures
The estimated PWUD population size of 13,000 [15] and
the assumption that the prevalence of HIV would be
lower compared to the prevalence in the national survey
in 2012, justified on the basis of the scaled up provision
of community-based harm reduction services in recent
years [4, 6], informed the sample size calculation for this
survey. Using an estimated HIV prevalence of 3.5%, a
margin error of 1.5%, a confidence interval of 95%, a re-
sponse rate of 90%, and a design effect of 1.5, we derived
a minimum sample size of 1390 for this study. The cal-
culated sample size was further stratified by study sites,
and roughly 15% of the estimated PWUD in each site
were recruited. Data collection was conducted in 21 lo-
cations: six locations in Phnom Penh and 15 locations in
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the remaining 11 provinces. The precise number of the se-
lected locations was determined based on the required sam-
ple size in each study site. The Respondent Driven Sampling
(RDS) method was used to recruit study participants.
The RDS was implemented in five stages. First, eligible
four seeds who were well connected to other PWUD in
each location were invited to participate in the survey
with support from a non-governmental organization
(NGO) working in the area. A written informed consent
was obtained from them. Second, each seed was given a
Personal Identification Number (PIN) and enrolled as a
participant. Third, each seed received three coupons and
were asked to refer three additional PWUD. They would
receive US$2 for a successful referral. Each seed was ex-
pected to extend up to three to six “recruitment waves”
at each site. If the initial seeds did not recruit participants
or if the enrollment has been halted because all recruit-
ment chains have “dried up” (i.e. stopped recruiting), add-
itional seeds would be selected based on the inclusion
criteria. Finally, recruited individuals were provided the
same opportunity as seeds to recruit other PWUD. In
total, 84 seeds were selected for the entire survey.
Data collection training
All data collection team members participated in a
three-day training workshop, which covered a review of
the study protocol, data collection methods, tool pretest-
ing, and reflection. The training also included interview
techniques, confidentiality, and privacy and provided the
study teams with an opportunity to practice question-
naire administration. The training facilitators explained
the study protocol and tools in details during the ses-
sions to ensure that all team members were thoroughly
familiar with it. A regular daily review session with data
collection teams were conducted during the survey
period to review progress and communicate any issues
encountered during the data collection.
Data collection procedures
HIV and syphilis test
HIV and syphilis screening were performed by a labora-
tory technician using SD Bioline HIV/Syphilis Duo test.
A non-HIV reactive result established that an individual
was not HIV-infected. In the case of an HIV reactive re-
sult from the SD Bioline HIV/Syphilis Duo test, a con-
firmatory test was conducted on site using HIV 1/2
STAT-PAK® Assay. The participants were given an op-
tion to receive their screening results verbally in a post-
test counseling session after the questionnaire interview.
A follow-up on newly detected HIV-infected individuals
was pursued closely by a local NGO working in the area.
Participants received a token gift, which costed approxi-
mately US$5, to compensate them for their time and
transport expenses.
Questionnaire development and measures
A structured questionnaire was developed using stan-
dardized tools adapted from previous studies among
HIV key populations in Cambodia and the most recent
Cambodia Demographic and Health Survey [14–18].
The questionnaire was initially designed in English and
then translated into Khmer, the national language of
Cambodia. Another translator then back-translated it into
English to ensure that the “content and spirit” of every ori-
ginal item were maintained. A consultative meeting was
held with representatives of PWUD and key stakeholders
working on HIV and harm reduction in Cambodia. A pilot
study was conducted with 20 PWUD in Phnom Penh,
who were later excluded from the main study.
Socio-demographic characteristics included geograph-
ical location of the study site (urban or rural), age (con-
tinuous), gender, level of education attained (continuous),
average monthly income in the past 6 months (continu-
ous), living situations, and employment status. Regarding
drug use, we collected information on types of illicit drugs
most commonly used and frequency of use in the past 3
months. We also collected information regarding expos-
ure to community-based HIV, harm reduction, and other
related services in the past 6 months. To measure HIV
risks, participants were asked about their sexual behaviors
in the past 3 months including number of partners and
condom use with commercial (defined as a partner with
whom the participant had sex in exchange for money or
goods) and non-commercial partners in the past 3
months. Other collected information included HIV testing
history, STI symptoms, and care seeking behaviors as well
as the use of other substances (tobacco and alcohol) in the
past 3 months.
Data analyses
The prevalence of HIV was calculated by dividing the
total number of participants tested positive for HIV with
the total number of participants tested. In bivariate ana-
lyses, we compared characteristics and behavioral vari-
ables of participants who were HIV positive to those of
participants who were HIV negative. Chi-square test (or
Fisher’s exact test for an expected cell value of ≤5) was
used for categorical variables, and Student’s t-test or
Mann-Whitney U test for continuous variables. To fa-
cilitate the analyses, age, level of education, and income
were transformed into categorical variables. A multivari-
able logistic regression model was constructed to iden-
tify independent factors associated with HIV infection.
Variables with a significance level of p < 0.05 in the bi-
variate analyses were simultaneously included in the
model. Age, gender, level of education, and income were
included in the model regardless of the significance level
in bivariate analyses because they have been found asso-
ciated with HIV infection in previous studies.
Tuot et al. BMC Infectious Diseases          (2019) 19:515 Page 3 of 11
Ethical considerations
This study was approved by the National Ethics Com-
mittee for Health Research (NECHR) of the Ministry of
Health, Cambodia (No. 193 NECHR). Privacy and confi-
dentiality of the participants were protected by conduct-
ing the data collection in a private room and removing
all personal identifiers from the study documents. Partic-
ipants were fully informed about the voluntary nature of
the study as well as risks and benefits they may expect
from their participation in the study. A written informed
consent was obtained from each participant.
Results
Socio-demographic characteristics
This study included 1367 PWUD with a mean age of
28.0 years (SD = 7.7). As shown in Tables 1, 87.9% of the
participants were residing in urban communities, and
39.6% were female. Almost half (47.8%) had never been
married, and 52.9% had attained only primary education.
While 48.2% reported living with their parents or rela-
tives, 16.8% were living on the streets. The most com-
mon jobs included a laborer or farmer (38.6%) and an
entertainment worker (16.6%), while 11.6% were un-
employed. The majority of the participants (77.0%) re-
ported an average monthly income in the past 6 months
of <US$200. A significantly higher proportion of HIV-
positive participants were female (59.0% vs. 38.4%), were
in the age group of ≥35 (35.9% vs. 18.3%), had completed
only primary education (74.4% vs. 51.6%), lived on the
streets (28.2% vs. 16.1%), and had the main job as a sex
worker (14.1% vs. 3.3%) compared to HIV-negative group.
Prevalence of HIV
The prevalence of HIV was 5.7% (95% CI = 4.6–7.1%).
Provinces in the top-five highest prevalence of HIV were
Preah Sihanouk (13.6%), Battambang (9.3%), Banteay
Meanchey (8.6%), Siem Reap (6.0%), and Kampong
Chhnang (4.6%). No newly-identified HIV-positive par-
ticipants were found in Kampong Cham and Prey Veng.
More than one-third (35.2%) of the HIV-positive cases
were not aware of their status prior to the study. Of the
50 cases who were aware of their HIV status, 46 (92.0%)
were currently on ART.
Substance use
Table 2 shows that the median time since the partici-
pants started using drugs was 12months (IQR = 6–36).
The majority (93.1%) reported “smoking” as the method
of their first drug use and that they were firstly intro-
duced to drugs by their friends or co-workers (79.7%).
Methamphetamine (Yama or ice) was the most com-
monly used drugs in the past 3 months (95.1%), and only
1.8% reported having used injecting drugs in their life-
time. The use of other substances was also common,
with 31.5% reported alcohol drinking at least four times
per week, and 33.0% reported binge drinking (drinking
at least 5 units of alcohol in a single session) at least on
4 days per week in the past 3 months. Almost half
(44.8%) reported smoking at least 100 cigarettes in their
lifetime. The proportion of those who reported having
used injecting drugs in their lifetime was significantly
higher (10.6% vs. 1.2%) in HIV-positive group compared
to that in HIV-negative group.
Sexual behaviors
The majority of the participants (92.4%) reported being
sexually active in the past 3 months, with a median
number of sex partners of 1.0 (IQR = 1.0–3.0). As pre-
sented in Table 3, only 26.3% reported always using con-
doms with any types of partners, and 39.1% reported
having sexual intercourse when a partner was intoxi-
cated in the past 3 months. Of those who reported hav-
ing sex with partners not in exchange for money or
goods (n = 507), 23.2% reported always using condoms
with the non-commercial partners in the past 3 months.
Of the total participants, 38.5% reported having sex in
exchange for money or goods in the past 3 months; of
whom, 40.5% reported always using condoms with the
commercial partners over the same period. Despite their
overall high HIV risk, only 22.1% perceived that their
HIV risk was higher compared to that in the general
population. Compared to the HIV-negative group, a sig-
nificantly higher proportion of HIV-positive participants
reported always using condoms with any types of part-
ners (39.6% vs. 25.6%) and having sex in exchange for
money or gifts (58.5% vs. 37.3%) in the past 3 months. A
significantly higher proportion of HIV-positive partici-
pants perceived that their HIV risk was higher compared
to that in the general population (46.2% vs. 20.6%).
Sexually transmitted infections
As shown in Tables 4, 3.4% of participants were tested posi-
tive for syphilis, and 33.6% reported having had at least one
STI symptom in the past 12months. The most commonly
reported symptoms included abnormal urethral discharge
(79.5%), followed by having cuts or sores (15.6%) and swell-
ing (15.2%) around the genital area. Compared to HIV-
negative group, a significantly higher proportion of HIV-
positive participants reported having an STI symptom in
the past 12months (48.7% vs. 33.5%) and having cuts or
sores around the genital area (26.3% vs. 14.7%). However, a
significantly lower proportion of HIV-positive participants
reported having abnormal urethral discharge compared to
that of HIV-negative group (65.8% vs. 80.7%).
Access to community-based HIV services
Table 5 shows that 54.5% of the study participants re-
ported having received some form of community-based
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HIV services in the past 6 months. The services in-
cluded condom and lubricant distribution (81.7%),
HIV/syphilis testing (60.0%), HIV education (53.3%),
harm reduction (14.6%), drop-in services (13.6%), legal
support (4.5%), and drug rehabilitation (1.3%). Com-
pared to HIV-negative group, a significantly higher
proportion of HIV-positive participants reported
having received community-based HIV services in the
past 6 months (84.6% vs. 52.7%).
Factors associated with HIV infection
Independent factors associated with HIV infection are
shown in Table 6. After adjustment for other covariates in
the multivariable logistic regression model, HIV infection
Table 1 Socio-demographic characteristics of HIV-positive and HIV-negative PWUD
Socio-demographic characteristics Total
(n = 1367)
HIV test result
Positive (n = 78) Negative (n = 1289)
n (%) n (%) n (%) P-value*
Living in an urban community 1201 (87.9) 73 (93.6) 1128 (87.5) 0.11
Female gender 541 (39.6) 46 (59.0) 495 (38.4) < 0.001
Age group < 0.001
18–24 519 (38.0) 18 (23.1) 501 (38.9)
25–34 583 (42.7) 32 (41.0) 551 (40.4)
≥ 35 263 (19.3) 28 (35.9) 235 (18.3)
Current marital status 0.14
Never married 651 (47.8) 29 (37.2) 622 (48.5)
Married 498 (36.6) 33 (42.3) 465 (36.2)
Widowed/divorced/separated 212 (15.6) 16 (20.5) 196 (15.3)
Level of formal education attained < 0.001
Primary (0–6 years) 722 (52.9) 58 (74.4) 664 (51.6)
Secondary school (7–9 years) 287 (28.4) 13 (16.7) 374 (29.1)
High school or higher (≥10 years) 213 (15.6) 7 (9.0) 248 (19.3)
Living situation < 0.001
In the street (homeless) 229 (16.8) 22 (28.2) 207 (16.1)
With parents or relatives 659 (48.2) 20 (25.6) 639 (49.6)
In own dwelling 322 (23.6) 27 (34.6) 295 (22.9)
With friends 157 (11.5) 9 (11.5) 148 (11.5)
Main occupation 0.004
Unemployed 158 (11.6) 9 (11.5) 149 (11.6)
Hair dresser/beautician 76 (5.6) 4 (5.1) 72 (5.6)
Office worker 63 (4.6) 4 (5.1) 59 (4.6)
Laborer/farmer 528 (38.6) 22 (28.2) 506 (39.3)
Self-employed 152 (11.1) 7 (9.0) 145 (11.2)
Entertainment worker† 227 (16.6) 15 (19.2) 212 (16.4)
Sex worker 53 (3.9) 11 (14.1) 42 (3.3)
Student 38 (2.8) 0 (0.0) 38 (2.9)
Other 72 (5.3) 6 (7.7) 66 (5.1)
Average monthly income in the past 6 months (US$) 0.57
< 100 493 (36.2) 31 (39.7) 462 (36.0)
100–199 556 (40.8) 27 (34.6) 529 (41.2)
200–299 199 (14.6) 11 (14.1) 188 (14.6)
≥ 300 115 (8.4) 9 (11.5) 106 (8.2)
HIV, human immunodeficiency virus; PWUD, people who use drugs; US$, United States dollar
*Chi-square (or Fisher’s exact test when a cell count was smaller than 5) was used
†Entertainment workers, often women, work in entertainment establishments such as karaoke bars, beer gardens, and massage parlors
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Table 2 Characteristics of substance use among HIV-positive and HIV-negative PWUD
Drug use characteristics Total
(n = 1367)
HIV test result
Positive (n = 78) Negative (n = 1289)
n (%) n (%) n (%) P-value*
Method of first illicit drug use 0.81
Injecting 3 (0.2) 0 (0.0) 3 (0.2)
Smoking 1273 (93.1) 75 (96.2) 1198 (92.9)
Sniffing or snorting 76 (5.6) 73 (5.7) 3 (3.8)
Swallowing/drinking 15 (1.1) 15 (1.1) 0 (0.0)
First-time drug use was introduced to drugs by: 0.60
Myself 206 (15.1) 10 (12.8) 196 (15.2)
Friends/co-workers 1089 (79.7) 66 (84.6) 1023 (79.4)
Sexual partners 58 (4.2) 2 (2.6) 56 (4.3)
Stranger (forced by) 13 (1.0) 0 (0.0) 13 (1.0)
Used illicit drugs in the past 3 months 1053 (77.8) 66 (84.6) 987 (77.4) 0.13
Type of illicit drugs commonly used in the past 3 months
Yama/ice (methamphetamine) 1014 (95.1) 63 (62.8) 951 (95.1) 0.90
Ecstasy 59 (5.5) 5 (7.6) 54 (5.4) 0.46
Inhalants 48 (4.5) 7 (10.6) 41 (4.1) 0.06
Cannabis 35 (3.3) 5 (7.6) 30 (3.0) 0.08
Having injected illicit drugs in lifetime 19 (1.8) 7 (10.6) 12 (1.2) < 0.001
Alcohol drinking ≥4 times per week 429 (31.5) 23 (29.5) 406 (31.6) 0.70
Binge drinking ≥4times per week 374 (33.0) 354 (32.9) 20 (34.5) 0.80
Smoked at least 100 cigarettes in lifetime 611 (44.8) 32 (41.0) 579 (45.0) 45.0
HIV, human immunodeficiency virus; PWUD, people who use drugs
*Chi-square test (or Fisher’s exact test when a cell count was smaller than 5) was used
Table 3 Sexual behaviors and perceived HIV risk among HIV-positive and HIV-negative PWUD
Sexual behaviors in the past 3 months Total
(n = 1367)
HIV test result
Positive (n = 78) Negative (n = 1289)
n (%) n (%) n (%) P-value*
Had sexual intercourse 1263 (92.4) 75 (96.2) 1188 (92.2) 0.20
Median number of sex partners (IQR) 1.0 (1.0–3.0) 1.0 (0.0–0.4) 1.0 (1.0–3.0) 0.60
Always used condoms with any type of partners 254 (26.3) 21 (39.6) 233 (25.6) 0.02
Had sex when partner was intoxicated 375 (39.1) 22 (43.1) 353 (38.8) 0.54
Had sex with non-commercial partners (n = 966) 507 (52.5) 30 (56.6) 477 (52.3) 0.54
Always used condoms with non-commercial partners (n = 507) 119 (23.2) 10 (32.3) 109 (22.7) 0.22
Had sex in exchange for money or gifts (n = 966) 372 (38.5) 31 (58.5) 341 (37.3) 0.002
Always used condoms with commercial partners (n = 372) 150 (40.5) 15 (48.4) 135 (39.8) 0.35
Perceived HIV risk compared to the general population < 0.001
Higher 301 (22.1) 36 (46.2) 265 (20.6)
About the same 438 (32.2) 24 (30.8) 414 (32.2)
Lower 219 (16.1) 7 (9.0) 212 (16.5)
Don’t know 404 (29.7) 11 (14.1) 393 (30.6)
HIV, human immunodeficiency virus; IQR, interquartile range; PWUD, people who use drugs
*Chi-square test was used for categorical variables and Mann-Whitney U test for continuous variables
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remained significantly associated with being in the age
group of ≥35 (AOR = 2.34, 95% CI = 1.04–6.11), having
lower level of formal education of ≤ 6 years (AOR = 2.26,
95% CI = 1.04–5.15), living on the streets (AOR = 2.82,
95% CI = 1.10–7.23), perception that their HIV risk was
higher as compared to that of the general population
(AOR = 3.18, 95% CI = 1.27–8.62), having used injecting
drugs in lifetime (AOR = 3.8, 95% CI = 1.36–4.56), and
having cuts or sores around the genital area in the past 12
months (AOR = 3.42, 95% CI = 1.09–6.33).
Discussion
This paper presents crucial data regarding the prevalence
of HIV and its risk factors among Cambodian PWUD
sampled in the most recent national IBBS conducted in
2017. The findings present useful information related to
the profile of substances used by the participants. Meth-
amphetamines were particularly prominent in the profile
of substances recently consumed (95.1%), while ecstasy,
cannabis, and other inhalants feature less, having been
used by 3.0 to 5.4% of the participants. These findings
concur with previous studies that have reported the ubi-
quity of methamphetamines in Cambodia [19–22]. As ex-
pected, most PWUD used drugs by way of smoking, while
fewer others snorted or swallowed them. A small propor-
tion (0.2%) had a history of drug injection in their lifetime,
even though this was more than 12months prior to the
survey.
Overall, we found that the prevalence of HIV was
5.7%, about 10 times higher than the prevalence in the
general adult population [6]. This finding confirms that
non-injecting drug users are highly vulnerable to HIV
infection. Independent risk factors of HIV infection
identified in this study included older age, lower level of
education, homelessness, perception of high level of HIV
risk, previous drug injection, and STI symptoms. These
findings warrant further discussion.
To start with, these findings suggest that older age
may be related to the risk of HIV infection. This is in
contrast to other studies in China and South Africa,
which did not find a relationship between HIV infection
and age among methamphetamine users [23, 24].
Table 4 Sexually transmitted infections among HIV-positive and HIV-negative PWUD
STI symptoms in the past 12 months Total
(n =
1367)
HIV test result
Positive (n = 78) Negative (n = 1289)
n (%) n (%) n (%) P-value*
Tested positive for syphilis 47 (3.4) 5 (6.4) 42 (3.3) 0.14
Had an STI symptom 470 (34.4) 38 (48.7) 432 (33.5) 0.006
Cuts or sores around genital area 73 (15.6) 10 (26.3) 63 (14.7) 0.04
Swelling around genital area 71 (15.2) 5 (13.2) 66 (15.3) 0.72
Abnormal urethral discharge 372 (79.5) 25 (65.8) 347 (80.7) 0.02
Symptoms around the anus 23 (4.9) 4 (10.5) 19 (4.4) 0.10
Symptoms in the mouth or throat 40 (10.0) 5 (13.2) 42 (9.8) 0.51
Received treatment for most recent STI 373 (80.2) 32 (84.2) 341 (79.9) 0.52
HIV, human immunodeficiency virus; STI, PWUD, people who use drugs; sexually transmitted infections
*Chi-square or Fisher’s exact test was used as appropriate
Table 5 Access to community-based HIV services among HIV-positive and HIV-negative PWUD
Access to community-based HIV ser-
vices in the past 6 months
Total
(n = 1367)
HIV test result
Positive (n = 78) Negative (n = 1289)
n (%) n (%) n (%) P-value*
Received community-based HIV services 745 (54.5) 66 (84.6) 679 (52.7) < 0.001
HIV education material distribution 251 (53.3) 28 (58.8) 223 (53.2) 0.92
Condom and lubricant distribution 385 (81.7) 39 (75.0) 346 (82.6) 0.18
Needle and syringe distribution 69 (14.6) 4 (7.7) 65 (15.5) 0.13
HIV/syphilis testing services 283 (60.0) 27 (51.9) 256 (61.1) 0.20
Legal support services 21 (4.5) 1 (1.9) 20 (4.8) 0.35
Drop-in services 64 (13.6) 7 (13.5) 57 (13.6) 0.98
Rehabilitation services 6 (1.3) 0 (0.0) 6 (1.4) 0.39
HIV, human immunodeficiency virus; PWUD, people who use drugs
*Chi-square or Fisher’s exact test was used as appropriate
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However, a previous study among transgender in
Cambodia reported that older age increased the risk of
HIV infection [25]. Bivariate findings in our study sug-
gested that duration of use is predictive of HIV infection,
and the duration was also identified as predictive of ac-
quisition of HIV and hepatitis C virus infections in
China [23]. As PWUD continue to consume drugs, the
cumulative chances of HIV acquisition would be ex-
pected to increase over time, especially if these drugs are
consumed in environments that promote risky sexual
practices. Our study suggests that this could be the case.
For instance, 31.5% of the participants reported alcohol
drinking at least four times per week, and 33.0% re-
ported binge drinking at least on 4 days per week in the
past 3 months. Furthermore, the prevalence of transac-
tional sex and STIs in our sample was considerably high,
and genital ulcers were independently predictive of HIV
infection. Stimulants such as methamphetamine and ec-
stasy are particularly associated with risky sexual practices
such as unprotected or transactional sex with multiple
partners [7, 26, 27] through enhanced sexual desire [28].
Not surprisingly, history of having used injecting drugs
was associated with higher likelihood of being diagnosed
with HIV. This is consistent with assertions that inject-
ing drug use is a potential risk factor for HIV due to the
risk of sharing contaminated needles [7]. Together with
the above assertions, this finding suggests that users of
stimulants predominantly expose themselves to HIV
sexually, while drug injection can also determine HIV
acquisition among those who transition to injecting,
even temporarily. The finding that a history of drug in-
jection tripled the odds of HIV infection provides a
compelling reason to reach out to people who are cur-
rently using drugs by routes other than injection, as
some of them may have injected in the past, often over a
year ago as was the case in our study. Taking the history
of lifetime drug injection provides a programmatically
useful way of stratifying risk among current PWUD.
Stratifying profiles of HIV risk could be an important
and cost-effective strategy for ensuring that every HIV
infection is identified within the current 90–90-90 global
goals and the Cambodia’s 3.0 strategy.
A quarter of the respondents in this study perceived
that they were at higher risk of HIV infection compared
to the general population. HIV was more likely to occur
among these PWUD who perceived that they were at
high HIV risk, perhaps based on their sexual behaviors,
which is not necessarily surprising. Perception of risk
has been shown to influence the uptake of HIV preven-
tion interventions [29], and to act in association with
contextual factors to influence the risk of HIV infection
[30]. As noted in Table 5, the majority of the respon-
dents in this survey had been reached with a range of
community-based HIV programs, including risk reduc-
tion education interventions and education related to
their risks. It is therefore reasonable to expect that these
populations would be aware of risks of HIV infection.
The importance of our findings, however, is that partici-
pants who clearly thought they were at high risk might
have not been taken measures to reduce those risks,
leading to their acquisition of HIV infection. This discor-
dancy might be explained by a lack of self-efficacy to re-
duce their exposure to HIV, or a range of external
determinants that could reduce their ability to manage
their exposure to HIV despite being aware of risks.
Determinants of health behaviors such as low self-
efficacy, low motivation, and external barriers have been
shown to prevent PWID in India from accessing health
services [31]. Data showing the complex interplay be-
tween recognition of vulnerability, rationalization of risk,
and inaction to protect oneself from HIV despite high-
risk perception has been reported among heterosexual
women in Kenya and South Africa [30]. Therefore, it is
Table 6 Factors associated with HIV infection among PWUD in
a multivariate logistic regression model
Variables in the final model AOR (95% CI) P-value
Age group
< 25 Reference
25–34 0.91 (0.37–2.26) 0.84
≥ 35 2.34 (1.04–6.11) 0.04
Level of formal education attained
High school or higher (≥10 years) Reference
Secondary school (7–9 years) 1.07 (0.41–2.77) 0.89
Primary (0–6 years) 2.26 (1.04–5.15) 0.04
Living situation
With family Reference
On the streets (homeless) 2.82 (1.10–7.23) 0.03
In own dwelling 1.73 (0.67–4.44) 0.26
With friends 0.94 (0.27–3.29) 0.92
Perceived HIV risk compared to the general population
Lower Reference
About the same 1.56 (0.52–4.70) 0.43
Higher 3.18 (1.27–8.62) 0.004
Having used injecting drugs in lifetime
No Reference
Yes 3.81 (1.36–4.56) 0.001
Having cuts or sores around the genital area in the past 12 months
No Reference
Yes 3.48 (1.09–6.33) 0.008
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HIV, human
immunodeficiency virus; PWUD, people who use drugs
*Age, gender, marital status, education level, and variables associated with HIV
infection in the bivariate analyses at a level of p < 0.05 were simultaneously
included in the model
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not entirely implausible that a range of barriers pre-
vented PWUD who thought that they were at high risk
from adopting safer behaviors. However, the validity of
this speculation will need to be explored specifically
among this sub-population who perceive higher risk of
HIV compared to the general population. Previous stud-
ies conducted in Cambodia have highlighted that the
lack of an enabling environment perpetuated by legal
and social factors impedes PWUD’s access to health ser-
vice including HIV prevention and care, and thus threat
efforts to control HIV among PWUD [14, 32]. Future re-
search should seek to understand how perceived high
HIV risk is actioned or otherwise rationalized, leading to
inaction, among PWUD in our study setting. This is par-
ticularly important given that more than one-third
(35.2%) of the HIV-positive cases were not aware of their
status prior to the survey.
An important finding from this study is that PWUD
who lived on the streets were more likely to be infected
with HIV. Previous studies have shown the impact of
lack of housing on risky substance use and sexual behav-
iors among PWUD, including those who used amphet-
amine and ecstasy [33–35]. Structural disadvantages,
such as homelessness, are known to encourage high-risk
behaviors by providing environments for experimenta-
tion among street-dwellers [36]. This finding is import-
ant as it provides an additional and practically useful
way in which to stratify profiles of risk among PWUD,
while suggesting that structural shelter accommodation
could be useful. At the same time, programs should
place a higher emphasis on homeless PWUD, ensuring
that outreach workers provide intensive education and
support to this population.
Finally, an expected finding from this study was the
observation that lower education predicted higher risk
of HIV infection. Previous studies in Cambodia have
shown that both substance use and HIV infection are as-
sociated with lower levels of education [25, 37]. This
finding adds additional impetus for reaching PWUD
with information and education regarding harms of drug
use, with relevant and easy-to-access materials, or
through peer-led approaches, prioritizing those that have
low literacy and education levels.
Limitations of the study
In interpreting the findings from this survey, several lim-
itations should be borne in mind. First, this was a cross-
sectional study which provides a snapshot of the preva-
lence of HIV and related risk behaviors, and does not
capture the dynamic way in which profiles and modes of
drug use change in the life course [38]. Second, this sur-
vey was conducted in 12 provinces with a high burden
of HIV and drug use, leaving out some 13 other prov-
inces with lower prevalence of both HIV and drug use.
This may affect the generalizability of the study findings
at the national level. Third, self-reporting measures were
used to collect a number of correlates, which are likely
to be affected by social desirability bias known to affect
reporting of sensitive drug use and sexual behaviors [39].
Finally, this survey used incentives in the RDS sampling
to recruit the participants, which may have affected
PWUD’s genuine motivation to participate. However, we
anticipate that the resultant motivational bias had min-
imal impact on our overall findings.
Conclusions
Strengthening the strategic information related to illicit
drug use is one of the five objectives of the Cambodian
National Strategic Plan on Harm Reduction [5]. This
study reports an HIV prevalence of 5.7% among 1367
PWUD recruited from the capital city and 11other major
provinces out of the 25 provinces in the countries. A
range of factors independently associated with HIV in-
fection are reported; these included older age, lower
education, homelessness, high-risk perception, history of
drug injection, and a recent history of genital ulcers or
sores. In addition, the study documents the predominance
of methamphetamines in the profile of non-injecting
drugs in the study context. This is an important addition
to the national strategic information related to illicit drug
use, as global studies related to amphetamine-type stimu-
lants (ATS) use tend to focus on men who have sex with
men and in high-income countries, with relatively limited
exploration of the use in low- and middle-income coun-
tries [40]. Given the findings of this study and to achieve
the national strategic goals of halting the HIV epidemic
among PWUD, our findings suggest that stratification of
risk based on socio-economic profiles and drug injection
history can enhance programs to identify unidentified
people living with HIV.
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